Hóa trị (Điều chỉnh liều hoặc tạm hoãn)

Corsetti MT, Salvi F, Perticone S, Baraldi A, De Paoli L, Gatto S, Pietrasanta D, Pini M, Primon V, Zallio F, Tonso A, Alvaro MG, Ciravegna G, Levis A.

Nguồn‎: Leuk Res 2011;35(8):991-7.

Mã bài‎: PubMed 21474179

DOI‎: 10.1016/j.leukres.2011.02.021

https://www.ncbi.nlm.nih.gov/pubmed/21474179 (mở cửa sổ mới)

Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. (mở cửa sổ mới)

Coutre SE, Othus M, Powell B, Willman CL, Stock W, Paietta E, Levitan D, Wetzler M, Attar EC, Altman JK, Gore SD, Maher T, Kopecky KJ, Tallman MS, Larson RA, Appelbaum FR.

Nguồn‎: Br J Haematol 2014;165(4):497-503.

Mã bài‎: PubMed 24528179

DOI‎: 10.1111/bjh.12775

https://www.ncbi.nlm.nih.gov/pubmed/24528179 (mở cửa sổ mới)

Low-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses. (mở cửa sổ mới)

Dainer PM, Knupp CL, Sartiano GP.

Nguồn‎: Am J Hematol 1992;40(2):156-7.

Mã bài‎: PubMed 1585917

https://www.ncbi.nlm.nih.gov/pubmed/1585917 (mở cửa sổ mới)

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. (mở cửa sổ mới)

Delarue R, Tilly H, Mounier N, Petrella T, Salles G, Thieblemont C, Bologna S, Ghesquières H, Hacini M, Fruchart C, Ysebaert L, Fermé C, Casasnovas O, Van Hoof A, Thyss A, Delmer A, Fitoussi O, Molina TJ, Haioun C, Bosly A.

Nguồn‎: Lancet Oncol 2013;14(6):525-33.

Mã bài‎: PubMed 23578722

DOI‎: 10.1016/S1470-2045(13)70122-0

https://www.ncbi.nlm.nih.gov/pubmed/23578722 (mở cửa sổ mới)

Azacitidine and venetoclax in previously untreated acute myeloid leukemia. (mở cửa sổ mới)

DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW

Nguồn‎: N Engl J Med 2020;383(7):617-29.

Mã bài‎: PubMed 32786187

DOI‎: 10.1056/NEJMoa2012971

https://www.ncbi.nlm.nih.gov/pubmed/32786187 (mở cửa sổ mới)

Treatment of acute leukaemia in adult Jehovah's Witnesses. (mở cửa sổ mới)

El Chaer F, Ballen KK

Nguồn‎: Br J Haematol 2020;190(5):696-707.

Mã bài‎: PubMed 31693175

DOI‎: 10.1111/bjh.16284

https://www.ncbi.nlm.nih.gov/pubmed/31693175 (mở cửa sổ mới)

Minimally-myelosuppressive asparaginase-containing induction regimen for treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS acute myeloid leukemia. (mở cửa sổ mới)

Emadi A, Bade NA, Stevenson B, Singh Z.

Nguồn‎: Pharmaceuticals (Basel) 2016;9(1):E12.

Mã bài‎: PubMed 27064021

DOI‎: 10.3390/ph9010012

https://www.ncbi.nlm.nih.gov/pubmed/27064021 (mở cửa sổ mới)

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. (mở cửa sổ mới)

Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T.

Nguồn‎: J Clin Oncol 2009;27(28):4733-40.

Mã bài‎: PubMed 19720927

DOI‎: 10.1200/JCO.2008.19.8721

https://www.ncbi.nlm.nih.gov/pubmed/19720927 (mở cửa sổ mới)

Successful treatment of a Jehovah's Witness with acute promyelocytic leukemia. (mở cửa sổ mới)

Fujita H, Maruta A, Koharazawa H, Hattori M, Tomit N, Kodama F, Mohri H, Okubo T.

Nguồn‎: Int J Hematol 1997;65(4):415-6.

Mã bài‎: PubMed 9195782

https://www.ncbi.nlm.nih.gov/pubmed/9195782 (mở cửa sổ mới)

Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia. (mở cửa sổ mới)

Garelius H, Grund S, Stockelberg D.

Nguồn‎: Clin Case Rep 2015;3(5):287-90.

Mã bài‎: PubMed 25984306

https://www.ncbi.nlm.nih.gov/pubmed/25984306 (mở cửa sổ mới)

Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness? (mở cửa sổ mới)

Juliusson G.

Nguồn‎: Am J Hematol 1996;53(1):49.

Mã bài‎: PubMed 8813099

DOI‎: 10.1002/(SICI)1096-8652(199609)53:1<49::AID-AJH12>3.0.CO;2-Z

https://www.ncbi.nlm.nih.gov/pubmed/8813099 (mở cửa sổ mới)

Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat. (mở cửa sổ mới)

Laszlo D, Agazzi A, Goldhirsch A, Cinieri S, Bertolini F, Rabascio C, Pruneri G, Calabrese L, Cocquio A, Martinelli G.

Nguồn‎: Eur J Haematol 2004;72(4):264-7.

Mã bài‎: PubMed 15089764

DOI‎: 10.1111/j.0902-4441.2003.00211.x

https://www.ncbi.nlm.nih.gov/pubmed/15089764 (mở cửa sổ mới)

Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin. (mở cửa sổ mới)

Lin CP, Huang MJ, Liu HJ, Chang IY, Tsai CH.

Nguồn‎: Am J Hematol 1996;51(3):251-2.

Mã bài‎: PubMed 8619417

DOI‎: 10.1002/(SICI)1096-8652(199603)51:3<251::AID-AJH20>3.0.CO;2-I

https://www.ncbi.nlm.nih.gov/pubmed/8619417 (mở cửa sổ mới)

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. (mở cửa sổ mới)

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

Nguồn‎: Hematol Oncol 2014;32(1):40-6.

Mã bài‎: PubMed 23963734

DOI‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 (mở cửa sổ mới)

Cytarabine dose for acute myeloid leukemia. (mở cửa sổ mới)

Löwenberg B, Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Biemond BJ, Gratwohl A, de Greef GE, Verdonck LF, Schaafsma MR, Gregor M, Theobald M, Schanz U, Maertens J, Ossenkoppele GJ; Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group.

Nguồn‎: N Engl J Med 2011;364(11):1027-36.

Mã bài‎: PubMed 21410371

DOI‎: 10.1056/NEJMoa1010222

https://www.ncbi.nlm.nih.gov/pubmed/21410371 (mở cửa sổ mới)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (mở cửa sổ mới)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Nguồn‎: Bone Marrow Transplant 2003;32(4):433-6.

Mã bài‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (mở cửa sổ mới)

Ivosidenib and azacitidine in IDH1-mutated acute myeloid leukemia. (mở cửa sổ mới)

Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G, Heuser M, Calado RT, Schuh AC, Yeh SP, Daigle SR, Hui J, Pandya SS, Gianolio DA, de Botton S, Döhner H

Nguồn‎: N Engl J Med. 2022;386(16):1519-31.

Mã bài‎: PubMed 35443108

DOI‎: 10.1056/NEJMoa2117344

https://pubmed.ncbi.nlm.nih.gov/35443108/ (mở cửa sổ mới)

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer. (mở cửa sổ mới)

Nagel CI, Backes FJ, Hade EM, Cohn DE, Eisenhauer EL, O'Malley DM, Fowler JM, Copeland LJ, Salani R.

Nguồn‎: Gynecol Oncol 2012;124(2):221-4.

Mã bài‎: PubMed 22055764

DOI‎: 10.1016/j.ygyno.2011.10.003

https://www.ncbi.nlm.nih.gov/pubmed/22055764 (mở cửa sổ mới)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (mở cửa sổ mới)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Nguồn‎: Leuk Res Rep. 2022 25;18:100355.

Mã bài‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (mở cửa sổ mới)

Developing a blood conservation care plan for Jehovah's Witness patients with malignant disease. (mở cửa sổ mới)

Norfolk DR, Wade P, Carter R.

Nguồn‎: Presented at the British Society for Haematology 47th Annual Scientific Meeting, Bournemouth [UK] April 2007.

https://www.transfusionguidelines.org/document-library/documents/developing-a-blood-conservation-care-plan-for-jehovah-s-witness-patients-with-malignant-disease/download-file/bbt-JW-Care-Plan-Malignant-Disease-2012.pdf (mở cửa sổ mới)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (mở cửa sổ mới)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Nguồn‎: Leuk Lymphoma. 2019;60(9):2324-7.

Mã bài‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (mở cửa sổ mới)

Hematopoietic growth factors: personalization of risks and benefits. (mở cửa sổ mới)

Puhalla S, Bhattacharya S, Davidson NE.

Nguồn‎: Mol Oncol 2012;6(2):237-41.

Mã bài‎: PubMed 22497867

DOI‎: 10.1016/j.molonc.2012.03.001

https://www.ncbi.nlm.nih.gov/pubmed/22497867 (mở cửa sổ mới)

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. (mở cửa sổ mới)

Riedell PA, Wu M, Collins JM, Gideon JM, Jakubowiak AJ, Kline JP, Kosuri S, Liu H, Smith SM, Bishop MR

Nguồn‎: Leuk Lymphoma 2021;62(6):1497-501.

Mã bài‎: PubMed 33535838

DOI‎: 10.1080/10428194.2021.1876868

https://www.ncbi.nlm.nih.gov/pubmed/33535838 (mở cửa sổ mới)

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia. (mở cửa sổ mới)

Roboz GJ, DiNardo CD, Stein EM, de Botton S, Mims AS, Prince GT, Altman JK, Arellano ML, Donnellan W, Erba HP, Mannis GN, Pollyea DA, Stein AS, Uy GL, Watts JM, Fathi AT, Kantarjian HM, Tallman MS, Choe S, Dai D, Fan B, Wang H, Zhang V, Yen KE, Kapsalis SM, Hickman D, Liu H, Agresta SV, Wu B, Attar EC, Stone RM

Nguồn‎: Blood 2020;135(7):463-71.

Mã bài‎: PubMed 31841594

DOI‎: 10.1182/blood.2019002140

https://www.ncbi.nlm.nih.gov/pubmed/31841594 (mở cửa sổ mới)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (mở cửa sổ mới)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Nguồn‎: Bone Marrow Transplant 2005;36(8):715-20.

Mã bài‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (mở cửa sổ mới)

A Mexican way to cope with stem cell grafting. (mở cửa sổ mới)

Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Nguồn‎: Hematology 2012;17 Suppl 1:S195-7.

Mã bài‎: PubMed 22507819

DOI‎: 10.1179/102453312X13336169157130

https://www.ncbi.nlm.nih.gov/pubmed/22507819 (mở cửa sổ mới)

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (mở cửa sổ mới)

Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F.

Nguồn‎: Blood 2009;113(9):1875-91.

Mã bài‎: PubMed 18812465

DOI‎: 10.1182/blood-2008-04-150250

https://www.ncbi.nlm.nih.gov/pubmed/18812465 (mở cửa sổ mới)

SCT in Jehovah's Witnesses: the bloodless transplant. (mở cửa sổ mới)

Sloan JM, Ballen K.

Nguồn‎: Bone Marrow Transplant 2008;41(10):837-44.

Mã bài‎: PubMed 18246110

DOI‎: 10.1038/bmt.2008.5

https://www.ncbi.nlm.nih.gov/pubmed/18246110 (mở cửa sổ mới)

Treatment of acute myelogenous leukemia with outpatient azacitidine. (mở cửa sổ mới)

Sudan N, Rossetti JM, Shadduck RK, Latsko J, Lech JA, Kaplan RB, Kennedy M, Gryn JF, Faroun Y, Lister J.

Nguồn‎: Cancer 2006;107(8):1839-43.

Mã bài‎: PubMed 16967444

DOI‎: 10.1002/cncr.22204

https://www.ncbi.nlm.nih.gov/pubmed/16967444 (mở cửa sổ mới)

Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's Witness. (mở cửa sổ mới)

van Akkooi AC, Golab-Schwarz HD, Eggermont AM, van Geel AN.

Nguồn‎: Eur J Cardiothorac Surg 2006;30(2):408-10.

Mã bài‎: PubMed 16829108

DOI‎: 10.1016/j.ejcts.2006.04.020

https://www.ncbi.nlm.nih.gov/pubmed/16829108 (mở cửa sổ mới)

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes. (mở cửa sổ mới)

Verstovsek S, Gotlib J, Gupta V, Atallah E, Mascarenhas J, Quintas-Cardama A, Sun W, Sarlis NJ, Sandor V, Levy RS, Kantarjian HM, Mesa RA.

Nguồn‎: Onco Targets Ther 2013;7:13-21.

Mã bài‎: PubMed 24368888

DOI‎: 10.2147/OTT.S53348

https://www.ncbi.nlm.nih.gov/pubmed/24368888 (mở cửa sổ mới)

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. (mở cửa sổ mới)

Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS.

Nguồn‎: J Clin Oncol 2007;25(30):4722-9.

Mã bài‎: PubMed 17947719

DOI‎: 10.1200/JCO.2007.12.2440

https://www.ncbi.nlm.nih.gov/pubmed/17947719 (mở cửa sổ mới)

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. (mở cửa sổ mới)

Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, Jiang Q, Mendes W, Hayslip J, Panayiotidis P

Nguồn‎: Blood 2020;135(24):2137-45.

Mã bài‎: PubMed 32219442

DOI‎: 10.1182/blood.2020004856

https://www.ncbi.nlm.nih.gov/pubmed/32219442 (mở cửa sổ mới)